- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Effect of oral administration of ethanolic extract of Vitex negundo on thioacetamide-induced nephrotoxicity in rats
© Kadir et al.; licensee BioMed Central Ltd. 2013
Received: 14 April 2013
Accepted: 24 October 2013
Published: 30 October 2013
Oxidative stress due to abnormal induction of reactive oxygen species (ROS) molecules is believed to be involved in the etiology of many diseases. Evidences suggest that ROS is involved in nephrotoxicity through frequent exposure to industrial toxic agents such as thioacetamide (TAA). The current investigation was designed to explore the possible protective effects of the leaves of Vitex negundo(VN) extract against TAA-induced nephrotoxicity in rats.
Twenty four Sprague Dawley rats were divided into four groups: (A) Normal control, (B) TAA (0.03% w/v in drinking water), (C) VN100 (VN 100 mg/kg + TAA) and (D) VN300 (VN 300 mg/kg + TAA). Blood urea and serum creatinine levels were measured,supraoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) levels of renal tissue were assayed. Histopathological analysis together with the oxidative stress nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p22phox in kidney sections were examined in all experimental groups.
Blood urea and serum creatinine levels were increased in TAA group as a result of the nephrotoxicity compared to the VN100 and VN300 groups where, the levels were significantly decreased (p < 0.05). Renal MDA level was significantly decreased (p < 0.05) in the VN-treated groups with increased CAT and SOD activities compared to the TAA group. Light microscopic examination of renal tissues stained by H&E stain and Masson’s Trichrome for TAA-treated groups revealed severe histopathological changes, whereas specimens obtained from VN-treated groups showed only mild changes. These findings were supported by immunohistochemical results.
VN extract acts as a natural potent antioxidant to prevent ongoing TAA-induced nephrotoxicity in rats, both biochemically and morphologically.
Kidneys are highly vulnerable to damage caused by reactive oxygen species (ROSs), likely due to oxidative stress by polyunsaturated fatty acids in the composition of renal lipids . This damage can also be caused by a high volume of blood flowing through it, and filtering large amounts of toxins, which can concentrate in kidney lobules . The kidney’s response to toxicants varies by multiple morphological patterns beginning with tubular or interstitial changes to nephropathy . It has been strongly implicated that (NADPH) oxidase, as a major source of ROSs production in the kidney  could have a role the in development of renal oxidative damage.
Nephrotoxicity is a poisonous effect due to drugs and its overdose on the kidneys. Thioacetamide (TAA) is an organic compound with the formula CH3CSNH2. It is originally used as a fungicide, and is a potent hepatotoxin . It can serve as a source of sulphur in the synthesis of organic compounds such as rubber chemicals, curing agents, cross linking agents, metallurgy, pesticides, and pharmaceuticals . TAA is the most potent nephrotoxic substance because of its rapid elimination and cumulative injury when it is given intermittently,presumably by free radical-mediated lipid [2, 6]. Metabolic studiesof TAA-induced tissue damage suggest that TAA is metabolized by the mixed function oxidase system to its toxic metabolites sulfine (sulfoxide) and sulfene (sulfone)which are then distributed among several organs,including plasma, liver, kidney, bone marrow, adrenals and other tissues . Later, TAA undergoes an extensive metabolism to acetate and it is excreted through the urine within 24 hours [5, 8].
Vitex negundo (VN) is commonly called five leaved chaste tree. It is a large aromatic shrub or small and slender with quadrangular branchlets, about 2 to 5 m in height, distributed mainly in tropical to temperate regions, especially in Malaysia, India at the warmest zones and Western Himalayas .
The leaves have a typical five foliolate pattern in palmate arrangement measuring4-10 cm long and bluish purple in colour which become dark when ripened. The whole parts of the plant have shown to be a potent source of natural antioxidants , 1, 2 di-substituted idopyranose, the isolated compound from VN extract has shown protection of hepatocytes, nephrocytes and pancreatic β-cells in streptozotocin-induced diabetes, probably by its action against NF-kB and induced-nitric oxide synthase iNOS mediated inflammation . A preliminary acute toxicity study of ethanolic leaf extract of VN in albino rats by oral rout carried out by Tandon, 2005  found it to be practically nontoxic, as its LD50 dose was recorded as 7.58 g/Kg body weight with no histomorphological changes in liver, kidney, stomach, heart and lung at any dose of the extract studied.VN has various traditional uses in treating stomach-ache, eye disease, inflammation, enlargement of spleen, bronchitis, asthma and painful teething in children. It is also used as an antihelmintic, promoting hair growth , and the juice of the leaves used in treating ulcers and swelling of joints . Literature review reveals that the plant of VN possesses analgesic and antinociceptive activity , hepatoprotective activity against TAA , antituberculardrugs , CCl4 and Ibuprofen via inhibition of lipid peroxidation .
In this study, VN extract was utilized in a rat model to evaluate its possible protective effects on TAA-induced nephrotoxicity. Data were collected on serum creatinine level, blood urea level, kidney and body weight ratio, glutathione content, and lipid peroxidation in the kidney tissues, as well as determination of p22phox expression and histopathological changes in the kidneys after administering VN extract in the adult male SD rats.
Collection and preparation of plant extract
Fresh leaves of VN plant were obtained from Kampung Baru, Sungai Ara, Penang, Malaysia. The botanical identity was determined and authenticated in the Department of Pharmacy, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia with voucher specimen number (KLU 34968). The plant was dried and grounded to a fine powder. Next, the powder was homogenized in 95% ethanol at a ratio of 1:10 of plant to ethanol, and left to soak for four days at 25°C with occasional shaking and stirring. Later, the mixture was filtered through filter paper, and the resulting liquid was concentrated at a reduced pressure at 45°C to obtain a dark gummy–green extract. The percentage yield of VN crude extract was 18%. The extract was then dissolved in Tween 20 (10% w/v) and administered orally to rats in concentrations of 100 and 300 mg/kg body weight.
Preparation of TAA
TAA (from Sigma-Aldrich, Switzerland) and all other chemicals used were of analytical grade and purchased mostly from Sigma-Aldrich and Fisher. TAA stock solution was prepared by dissolving30 mg pure TAA which is in crystal form in 100 ml distilled water (0.03% w/v) until all the crystals were dissolved. The solution was given to the rats as their daily drinking water .
A healthy adult male Sprague Dawley rats weighing 180–200 gm were obtained from the Animal House Unit, Faculty of Medicine, University of Malaya, Malaysia. They were kept in wire-bottomed cages at 25 ± 3°C, at 50–60% humidity, and a 12 h light-dark cycle for at least a week before the experiment. They were maintained under standard housing conditions with free access to a standard diet and water ad libitum during the experiment. The experimental protocol was approved by the Institutional Animal Care and Use Committee, University of Malaya (UM IACUC) with an ethical no. ANA/18/05/2012/FAAK. Throughout the experiment, all criteria for taking care of animals prepared by the National Academy of Sciences and outlined in the “Guide for the Care and Use of laboratory Animals” were compiled .
The animals were randomly divided into four experimental groups, with each group consisting of six rats, and given the following treatments: Group A: Normal control group, received per oral treatment of 10% Tween 20 (5 ml/kg) daily for 12 weeks; Group B: TAA group, received TAA 0.03% w/v in drinking water daily for 12 weeks; Group C: VN100 group, received TAA 0.03% w/v in drinking water and 100 mg/kg body weight of VN extract daily for 12 weeks; Group D: VN300 group,received TAA 0.03% w/v in drinking water and 300 mg/kg body weight of VN extract daily for 12 weeks.
The body weights of the animals were recorded weekly throughout the experimental period starting from Day 0. At the end of the 12th week, the rats were sacrificed 24 hours after the last treatment followed by overnight fasting. The rats were anaesthetized by intramuscular injection of 50 mg/kg ketamine mixed with xylazine 5 mg/kg. Blood samples were collected and serum was obtained for estimation of creatinine and blood urea levels. Kidney samples were dissected, trimmed of connective tissues, washed using normal saline to eliminate blood contamination, dried by blotting with filter paper and weighed. The kidneys were excised into two halves. One-half was kept in isotonic formalin for histopathological assessment and the other half was kept in the freezer under -80°C for preparing kidney homogenate for the malondialdehyde (MDA), catalase (CAT) and supraoxide dismutase(SOD) assays.
Assessment of renal function
A blood sample was withdrawn through the jugular vein and collected into a plain tube with activated gel for detection of urea and creatinine levels. The samples were allowed to clot, centrifuged and the serum samples were sent for analysis using a standard automated technique in the Central Diagnostic Laboratory (CDL), University of Malaya Medical Centre, according to the procedures described by the manufacturers.
Preparation of kidney homogenates
Kidney homogenates (10% w/v) were prepared by homogenizing kidney tissue in cold 50 mM potassium phosphate buffer saline (pH 7.4) using a tissue homogenizer (DAIHAN Sci., Seoul, Korea). The cell debris was removed by centrifugation at 4500 rpm for 15 minutes at 4°C using a refrigerated centrifuge Rotofix 32 (Hettich Zentrifugen, Germany). The supernatant was used for estimating the following in vivo antioxidant using commercially available kits (Cayman Chemical Company, USA): (MDA) or thiobarbituric acid reactive substance (TBARS) (Item No. 10009055), (CAT) (Item No. 707002) and (SOD) (Item No. 706002). All assays were performed according to the instruction manual of the manufacturers.
The lower half of the right kidney was examined for histopathological changes. All kidneys specimens were examined under a light microscope. The kidneys were fixed in 10% formalin and then embedded in paraffin wax before sectioning at 5 μm thickness and stained with haematoxylin-eosin and Masson’s trichrome stains. Kidney sections from the six rats in each group were examined by two dependent observers. Morphological analysis there were carried out according to Houghton et al.,  and were graded as follows: Grade 0 (normal), Grade 1 (when changes were limited to the tubulointerstitial areas of focal granulovascular epithelial cell degeneration and granular debris in the tubular lumina with or without evidence of desquamation in small foci (<1% of total tubule population involved by desquamation), Grade 2 (when tubular epithelial necrosis and desquamation were easily seen but involved less than half of the cortical tubules), Grade 3 (when more than half of the proximal tubules showing necrosis and desquamation, but with intact tubules easily identified, and Grade 4 (when there was complete or almost complete proximal tubular necrosis).
For the quantitative determination of anti-p22 phox antibody, immunohistochemistry kit for p22 phox (CS9): sc-130551 (Santa Cruz Biotechnology, INC.) was used. Briefly, sections were deparaffinized in xylene and hydrated in a series of graded alcohol. Deparaffinized sections were treated in a microwave oven in a citrate buffer at 95°C for 15 minutes, and immersed in 3% hydrogen peroxide in methanol for 10 min to abolish endogeneous peroxidase activities. The sections were immersed in normal goat serum for 15 min, incubated withmouse monoclonal antibody as a marker for NADPH oxidase subunits (diluted to 1:50) at 37°C for 60 min, and then incubated with goat anti-mouse IgG conjugated with horseradish\ peroxidise (HRP) (diluted to 1:200). The reaction products were visualized using 3-30-deiaminobenizidine tetrahydrochloride and hydrogen peroxide. A cytoplasmic brown granule was marked as positive expression of p22 phox.
All data were expressed as mean ± standard error of the mean (SEM) and statistical analysis was performed using SPSS for Windows version 17.0 (SPSS Inc. Chicago, IL, USA). One-way analysis of variance (ANOVA) followed by Bonferroni post hoc test was applied to test for statistically significant differences between groups at p < 0.05.
During the course of this study, continuous daily administration of 0.03% w/v TAA in drinking water was not associated with animal mortality. The external appearance of the kidneys from animals treated with TAA in drinking water as well as VN-treated groups revealed a smooth, glistening capsule with no petechial hemorrhage was noted.
Body and kidney weight
Effect of VN on body and kidney weights
Body weight (g)
Kidney weight (g)
219.8 ± 29.88**
0.95 ± 0.23
177.5 ± 7.1*
0.93 ± 0.119
VN100 + TAA
199.3 ± 15.98
0.94 ± 0.22
VN300 + TAA
204.3 ± 10.70
0.99 ± 0.29
Effect of VN on blood urea and serum creatininelevels
4.46 ± 0.45**
23 ± 1.7**
8.73 ± 1.31*
52.3 ± 7.5*
VN100 + TAA
6.28 ± 0.59*,**
35.66 ± 7.3*,**
VN300 + TAA
5.73 ± 0.973**
29.33 ± 3.4**
Effects of VN on some in vivo antioxidant parameters in all experimental groups
(U/mg protein )
27.24 ± 34.32
32.23 ± 7.14
38.74 ± 2.61
21.57 ± 24.87*
22.3 ± 8.58*
107.14 ± 3.71*
VN100 + TAA
24.75 ± 105.09
26.73 ± 0.93**
78.85 ± 2.26**
VN300 + TAA
25.26 ± 56.01
27.47 ± 3.44**
54.35 ± 1.73**
Various useful drugs like acetaminophen, gentamicin and some environmental and industrial toxicants can cause severe renal damage through activation of these drugs to highly reactive free radicals . One of the most extensively studied chemicals and industrial toxicants is TAA. TAA is known to induce centrilobular hepatic necrosis, liver cirrhosis, hepatocellular carcinoma and bile duct proliferation [5, 8, 16, 24, 25] with injury to the terminal portion of the proximal renal tubule . After administration of TAA, this chemical undergoes an extensive metabolism forming sulfine (sulfoxide) and sulfene (sulfone). Both are circulated through several vital organs in body before finally being transformed into acetate and excreted into urine within 24 hours .
TAA administration (0.03% w/v) in drinking water for 12 weeks found to cause renal toxicity as assessed by biochemical analysis of urea and creatinine, MDA and antioxidant status of SOD and CAT. As a measure of renal function status, blood urea and creatinine are often regarded as reliable markers . The increased urea and creatinine levels resulting from TAA administration in this study (Table 2), are in agreement with a previous study done by Begum et al., . High values of blood urea and serum creatinine indicate renal damage [27, 28] and this may be correlated with the significant and progressive weight loss in the TAA group (Table 1). As for the VN100 and VN300 groups, although there was increased body weight in both groups, the increase was not significantly different compared in the TAA group (Table 1).
From this study, pretreatment with VN 100 mg/kg extract could partly prevent TAA-induced kidney damage as shown by the decreasing levels of urea and creatinine. These parameters were almost significantly normalized by the administration of VN 300 mg/kg extract (Table 2). This result is consistent with many previous studies done using other traditional plants , and is strongly attributed to the scavenging free radicals and reduced lipid peroxidation mechanisms.
Free radicals are believed to play a major role in the development of TAA-induced toxicity , hence, when oxidative stress is overwhelming, the various inherent defense mechanisms such as the antioxidant defense mechanisms, intercellular concentration of CAT and SOD activities become significantly impaired and insufficient . This is because during oxidative stress, the body uses its defense mechanism to minimize the process of lipid peroxidation using these antioxidant enzymes, thus, the activity of these enzymes becomes higher in early stages of TAA induction. When the oxidative insult was continued for a long period, the enzymes become depleted and unable to fight against the free radicals, suggesting advance stages of TAA-induced peroxidation. This was evident in the present study with the significant increase (p < 0. 05) in MDA level, renal damage in TAA group compared to the normal control group.
Several phytochemical studies have revealed the presence of volatile oils, lignans, flavonoid like flavones, luteolin-7-glucoside and glycosides in VN . In addition, VN ethanolic extract possesses radical scavenging activity probably due to higher concentration of flavonoids and alkaloids . This was evident in the increased (CAT and SOD) levels in this study as well as the decreased in MDA level in the VN- treated groupsas shown in Table 3. Presumably, this is due to the antioxidant properties of the plant extract, which may account for the nephroprotective action of VN against TAA-induced nephrotoxicity experimental models.
Histopathological grading of the kidney sections for all experimental groups
Average of grades
3.33 ± 0.51*
VN 100 + TAA
2.00 ± 0.63**
VN 300 + TAA
1.16 ± 1.34**
The overall results from this study demonstrated TAA-induced renal injury by biochemical analysis, histopathological features and immunohistochemistry analysis. The concurrent treatment with VN extract clearly provided a considerable degree of protection in a dose-dependent manner against the deleterious renal side effects of TAA. In conclusion, VN could act on the kidney as a potent natural antioxidant to prevent ongoing TAA- induced nephrotoxicity, thus, these results constitute a lead towards discovering a novel herb in traditional and complementary medicine.
The authors express their gratitude to the staffs of the Faculty of Medicine, Animal House for the care and supply of rats. Financial support from (PG087-2012B) and (UM/MoHE/HIR Grant E000045-20001) from University of Malaya, Malaysia, are gratefully acknowledged.
- Ozbek E: Induction of Oxidative Stress in Kidney. Int J Nephrol. 2012, 2012: 1-9.View ArticleGoogle Scholar
- Begum Q, Noori S, Mahboob T: Antioxidant effect of sodium selenite on thioacetamide-induced renal toxicity. Pakistan Journal of Biochemistry and Molecular Biology. 2011, 44 (1): 21-26.Google Scholar
- Silva FG: Chemical-induced nephropathy: a review of the renal tubulointerstitial lesions in humans. Toxicol Pathol. 2004, 32 (2): 71-84.View ArticlePubMedGoogle Scholar
- Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H: Increased expression of NAD (P) H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia. 2003, 46 (10): 1428-1437. 10.1007/s00125-003-1205-6.View ArticlePubMedGoogle Scholar
- Kadir FA, Othman F, Abdulla MA, Hussan F, Hassandarvish P: Effect of Tinospora crispa on thioacetamide-induced liver cirrhosis in rats. Indian J Pharmacol. 2011, 43 (1): 64-68. 10.4103/0253-7613.75673.View ArticlePubMedPubMed CentralGoogle Scholar
- Dashti HM, Mathew TC, Jadaon MM, Ashkanani E: Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition. 1997, 13 (3): vi-212.View ArticleGoogle Scholar
- Edward A, Baker EAS: Nonhepatic Thioacetamide Injury. The morphologic Features of proximal renal tubular injury. Am J Pathol. 1974, 74 (3): 576-590.Google Scholar
- Spira B, Raw I: The effect of thioacetamide on the activity and expression of cytosolic rat liver glutathione-S-transferase. Mol Cell Biochem. 2000, 211 (1): 103-110.View ArticlePubMedGoogle Scholar
- Gautam L, Shrestha S, Wagle P, Tamrakar B: Chemical constituents from Vitex negundo (Linn.) of nepalese origin. Scientific world. 2010, 6 (6): 27-32.View ArticleGoogle Scholar
- Raghavendra H, Lakshmanashetty VBN, Madhumathi G, Hiremath aVK: In vitro Antioxidant Activity of Vitex negundo L. Leaf Extracts. Chiang Mai Journal of Science. 2010, 37 (3): 489-497.Google Scholar
- Manikandan R, Thiagarajan R, Beulaja S, Sivakumar MR, Meiyalagan V, Sundaram R, Arumugam M: 1,2 di-substituted idopyranose from Vitex negundo L. protects against streptozotocin-induced diabetes by inhibiting nuclear factor-kappa B and inducible nitric oxide synthase expression. Microsc Res Tech. 2011, 74 (4): 301-307.PubMedGoogle Scholar
- Tandon VR: Medicinal uses and biological activities of Vitex negundo. Natural product radiance. 2005, 4 (3): 162-165.Google Scholar
- Singh P, Mishra G, Srivastava S, Sangeeta K, Khosa R: Phytopharmacological review of vitex negundo (Sambhalu). Pharmacologyonline. 2011, 2: 1355-1385.Google Scholar
- Nadkarni KM: Dr. K. M. Nadkarni&s Indian materia medica. 1. 1994, Popular PrakashanGoogle Scholar
- Zheng C-J, Huang B-K, Han T, Zhang Q-Y, Zhang H, Rahman K, Qin L-P: Antinociceptive activities of the liposoluble fraction from Vitex negundo seeds. Pharm Biol. 2010, 48 (6): 651-658. 10.3109/13880200903241838.View ArticlePubMedGoogle Scholar
- Kadir FA, Kassim NM, Abdulla MA, Yehye WA: Hepatoprotective Role of Ethanolic Extract of Vitex negundo in Thioacetamide-Induced Liver Fibrosis in Male Rats. Evidence-Based Complementary and Alternative Medicine. 2013, 2013:Google Scholar
- Avadhoot Y, Rana A: Hepatoprotective effect of Vitex negundo against carbon tetrachloride-induced liver damage. Arch Pharm Res. 1991, 14 (1): 96-98. 10.1007/BF02857823.View ArticlePubMedGoogle Scholar
- Mahalakshmi R, Rajesh P, Balasubramanian V, Rajesh Kanan V: Hepatoprotective activity on Vitex negundo Linn.(Verbanaceae) by using Wistar albino rats in Ibuprofen induced model. Int J Pharmacol. 2010, 6 (5): 658-663.View ArticleGoogle Scholar
- Müller A, Machnik F, Zimmermann T, Schubert H: Thioacetamide-induced cirrhosis-like liver lesions in rats usefulness and reliability of this animal model. Exp Pathol. 1988, 34 (4): 229-236. 10.1016/S0232-1513(88)80155-5.View ArticlePubMedGoogle Scholar
- National research council. Guide for the care and use of laboratory animals. Washington, DC: The National Academies Press, 8Google Scholar
- Houghton DC, Plamp CE, DeFehr JM, Bennett WM, Porter G, Gilbert D: Gentamicin and tobramycin nephrotoxicity. a morphologic and functional comparison in the rat. Am J Pathol. 1978, 93 (1): 137-152.PubMedPubMed CentralGoogle Scholar
- Ercal N, Gurer-Orhan H, Aykin-Burns N: Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001, 1 (6): 529-539. 10.2174/1568026013394831.View ArticlePubMedGoogle Scholar
- Olagunju J, Adeneye A, Fagbohunka B, Bisuga N, Ketiku A, Benebo A, Olufowobi O, Adeoye A, Alimi M, Adeleke A: Nephroprotective activities of the aqueous seed extract of Carica papaya Linn. in carbon tetrachloride induced renal injured Wistar rats: a dose-and time-dependent study. Biol Med. 2009, 1 (1): 11-19.Google Scholar
- Stankova P, Kucera O, Lotkova H, Rousar T, Endlicher R, Cervinkova Z: The toxic effect of thioacetamide on rat liver in vitro. Toxicol In Vitro. 2010, 24 (8): 2097-2103. 10.1016/j.tiv.2010.06.011.View ArticlePubMedGoogle Scholar
- Madani H, Talebolhosseini M, Asgary S, Naderi G: Hepatoprotective activity of Silybum marianum and Cichorium intybus against thioacetamide in rat. Pakistan J Nutr. 2008, 7 (1): 172-176. 10.3923/pjn.2008.172.176.View ArticleGoogle Scholar
- Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AAK, Vernekar SN: Markers of renal function tests. North Am J Med Sci. 2010, 2 (4): 170-Google Scholar
- Adeneye AA, Benebo AS: Protective effect of the aqueous leaf and seed extract of Phyllanthus amarus on gentamicin and acetaminophen-induced nephrotoxic rats. J Ethnopharmacol. 2008, 118 (2): 318-323. 10.1016/j.jep.2008.04.025.View ArticlePubMedGoogle Scholar
- Khalid MS: Nephroprotective effect of the ethanolic extract of Lantana camara Linn flower on acute dose of Cisplatin induced renal injured rats. 2012Google Scholar
- El-Adawi H, El-Azhary D, Abd El-Wahab A, El-Shafeey M, Abdel-Mohsen M: Protective effect of milk thistle and grape seed extracts on fumonisin B1 induced Hepato-and nephro-toxicity in rats. J Med Plant Res. 2011, 5 (27): 6316-6327.View ArticleGoogle Scholar
- Mohammed AA, Mahmood Ameen A, Salmah I, Zahra AA: Hepatoprotective effects of Orthosiphon stamineus extract on thioacetamide-induced liver cirrhosis in rats. Evidence-Based Complementary and Alternative Medicine. 2011, 2011:Google Scholar
- Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, Acet A: Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology. 2005, 207 (2): 169-177. 10.1016/j.tox.2004.08.024.View ArticlePubMedGoogle Scholar
- Tiwari OP, Tripathi YB: Antioxidant properties of different fractions of Vitex negundo Linn. Food Chemistry. 2007, 100 (3): 1170-1176. 10.1016/j.foodchem.2005.10.069.View ArticleGoogle Scholar
- Leena P, Balaraman R: Effect of green tea extract on cisplatin induced oxidative damage on kidney and testes of rats. Ars Pharmaceutica. 2005, 46: 5-18.Google Scholar
- Hu Z, Ren L, Wang C, Liu B, Song G: Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed wistar rats. Kidney Blood Press Res. 2012, 36 (2): 85-97. 10.1159/000341485.View ArticlePubMedGoogle Scholar
- Sarumathya K, Vijay T, Jayakanthia J, Dhana M: A protective effect of Caesalpinia sappan (CS) on acetaminophen induced nephrotoxicity and oxidative stress in male albino rats. J Pharmacol Toxicol. 2011, 2: 11-21.Google Scholar
- Khan SA, Priyamvada S, Khan W, Khan S, Farooq N, Yusufi ANK: Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. Pharmacol Res. 2009, 60 (5): 382-391. 10.1016/j.phrs.2009.07.007.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/294/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.